.png)
According to the Centers for Medicare and Medicaid Services, healthcare spending by private health plans increased 8.8% to $1,644.6 billion in 2024. Despite sustained investment in healthcare cost containment strategies, total cost of care continues to rise, exposing a structural gap in how cost is managed.
Preventive care programs, network optimization, utilization management, and value-based care all play a role. Each addresses a specific dimension of cost, but none consistently alters the trajectory of total cost of care at scale. The most important care decisions occur when a member first acts on a symptom. Members determine an action without payer guidance, leveraging search engines or consumer AI tools which often lack clinical oversight. Often, members escalate care to high-cost settings, such as urgent care or EDs, contributing to unnecessary utilization of downstream services and increasing total cost of care. AI-enabled, physician-supervised primary care models give payers a way to intervene at the moment members seek care, improving cost containment.
Today's cost containment strategies operate across several dimensions. Each contributes meaningful value, but also operates downstream of the initial care decision.
Preventive care and chronic condition management reduce demand for high-cost interventions by addressing issues earlier in the disease trajectory. When engagement is consistent and access is timely, these programs can:
Both depend heavily on member engagement and access. When members delay care or lack a clear entry point, preventable conditions still escalate into higher-cost events.
Network strategies influence cost per service by directing members toward preferred providers and lower-cost settings. Effective network design can:
However, these strategies rely on influencing decisions after a member has already sought initial care. If the initial point of care is out-of-network or higher acuity than necessary, downstream optimization has limited impact.
Utilization management governs the appropriateness of high-cost interventions. It helps reduce unnecessary procedures and excessive utilization, but timing is important. Utilization management is inherently reactive. UM is applied after care has been initiated, intervening on what has already been ordered or recommended rather than on the decision that led there.
Value-based care models align provider incentives with total cost of care performance, holding accountable parties responsible for both quality and cost outcomes. When designed well, these arrangements reduce unnecessary utilization through provider-led care management. Their effectiveness still depends on referral patterns and patient flow. When members enter care through uncoordinated pathways, even aligned providers inherit inefficient starting points.
Cost varies dramatically across care settings, even for clinically similar presentations. Episodes routed through inpatient or emergency settings often cost multiples of the equivalent care delivered in outpatient or urgent care settings. Site-of-care optimization shifts utilization toward the lowest clinically appropriate setting, lowering cost per episode without compromising quality.
Impact depends on influencing where care begins. Once a member enters a high-acuity setting, cost is largely locked in.
Most cost-containment strategies are designed to manage costs after they are incurred, optimizing price and utilization within an established care pathway.
Today, members enter care through multiple uncoordinated channels, contributing to ongoing fragmentation in healthcare. There is no single, clinically governed intake layer to standardize decision-making, which is crucial for quality care and cost containment. The result is variation in acuity assessment, inconsistent routing, and materially different cost outcomes for similar conditions across the same population.
Research continues to quantify the impact of early decision-making on downstream cost. One frequently cited finding shows that approximately 24% of hospital admissions were unnecessary, yet accounted for roughly 12% of total hospital costs. These outcomes are not driven by isolated clinical errors. They reflect systemic issues in how members enter care.
When members lack clinical clarity at symptom onset, the safest perceived choice is often the highest-acuity setting. Without trusted clinical input at the point of entry into care, escalation becomes the path of least resistance.
Early intervention, particularly when care is informed by longitudinal context, can address concerns directly, reducing unnecessary specialist visits, imaging, and acute care utilization. A 2025 study published in NEJM AI evaluating an AI-supported diagnostic decision support tool deployed as a digital front door observed measurable shifts in care behavior, demonstrating that early, structured engagement can materially change downstream utilization patterns.
By shifting care upstream and aligning pathways to in-network providers and existing health solutions, health plans can reduce leakage. When members make decisions within a payer’s clinically governed front door to care, networks become more efficient, and the ROI of preferred provider arrangements improves.
Effective cost containment requires a change in the care model, not incremental improvements to existing strategies.
AI-enabled, physician-supervised primary care introduces a clinically governed front door that engages members when they need support the most. Solutions like Counsel operationalize this model, combining medical AI with in-house physicians to deliver care directly in a payer’s existing member experience. This integration enables complete customization of clinical protocols and the care interface, ensuring it aligns with a plan’s brand and every member interaction aligns with provider directories, networks, and ecosystem of health solutions.
That shift changes how care begins and how cost is determined. With Counsel, most issues are resolved without escalation, reducing avoidable utilization and improving site-of-care distribution. This model has been associated with a 24% reduction in unnecessary emergency department visits, improving overall ED utilization compared to consumer-facing AI tools
Scaling early intervention requires clinical governance, not just technology. Decisions that shape care pathways require physician accountability, defined escalation thresholds, and auditability. Without this kind of responsible AI governance, early intervention introduces clinical and regulatory risk.
Request a demo to see how a Counsel’s responsible, AI-enabled care model can reshape utilization, improve network performance, and reduce total cost of care.
The Counsel Health editorial team is a multidisciplinary group of writers and editors dedicated to delivering clinically grounded, evidence-based health information. Their work is informed by real-world care delivery and guided by physician expertise, ensuring content is accurate, accessible, and trustworthy. By translating complex medical topics into clear, practical guidance, the team helps readers understand their health, explore care options, and make informed decisions in a rapidly evolving healthcare landscape.
Javier Monterrosa is a healthcare marketing leader who has spent his career driving growth across AI, metabolic health, interoperability, and EHR companies. He holds a Master’s in Analytics and has co-authored published research examining how strategic decisions shape business growth. Having grown up in Latin America, he is driven to partner with mission-driven teams committed to improving healthcare access and outcomes through responsible technology.
Our content is created for informational purposes and should not replace professional medical care. For personalized guidance, talk to a licensed physician. Learn more about our editorial standards and review process.
.png)
